ADC Biotechnology (ADC Bio) has secured additional funding of £2.5 million from existing investors and company management. The finance will be deployed to ensure the achievement of specific
?ADC Biotechnology?(ADC Bio), announces that it has secured £1.14 million in funding from investment managers,?Downing LLP. The funds?will bolster the company’s business drive for faster penetration of the main US market.
Customer demand for ‘Lock-Release’ aggregation control technology a key driver behind the ADC Bio expansion into clinical and commercial drug manufacturing.